Your institution may have access to this item. Find your institution then sign in to continue.
Title
An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis.
Authors
Denton, C P; Engelhart, M; Tvede, N; Wilson, H; Khan, K; Shiwen, X; Carreira, P E; Diaz Gonzalez, F; Black, C M; van den Hoogen, F H
Abstract
The safety and potential efficacy of a chimaeric anti-tumour necrosis factor alpha monoclonal antibody (infliximab) were examined in diffuse cutaneous systemic sclerosis (dcSSc).
Publication
Annals of the rheumatic diseases, 2009, Vol 68, Issue 9, p1433